cinrebafusp alfa
pieris pharmaceuticals,servier
['prs-343']
pieris pharmaceuticals announces presentation of positive clinical data for cinrebafusp alpa (prs-343) at 2023 aacr annual meeting #stocksoftheday #stockalert #stocknews #cancer #event #newclinicaltrialdata 
Find the most important news and press releases about U.S. publicly-traded companies in real-time and stay ahead of the game!